Aimee Jost, MA, CCC-SLP | |
113 Comanche Rd, Fort Meade, SD 57741-1002 | |
(605) 347-7000 | |
Not Available |
Full Name | Aimee Jost |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 113 Comanche Rd, Fort Meade, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649302720 | NPI | - | NPPES |
5835270 | Medicaid | SD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Aimee Jost, MA, CCC-SLP 113 Comanche Rd, Fort Meade, SD 57741-1002 Ph: (605) 347-7000 | Aimee Jost, MA, CCC-SLP 113 Comanche Rd, Fort Meade, SD 57741-1002 Ph: (605) 347-7000 |
News Archive
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
Coffee drinkers are familiar with the ring-shaped stains that result from spilled drops that have dried, in which the brown stain is not evenly distributed, but instead concentrated at the edge.
Sleep - one of the most basic, yet most mystifying processes of the human body - has confounded physicians, scientists and evolutionary biologists for centuries.
A team of scientists from ASU's School of Molecular Sciences and the Biodesign Institute have recently published a study in Nature Communications that helps clarify the contributions to an ion channel's temperature - dependent activation. This in turn should aid in the development of new types of non-addictive pain therapies.
Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at the ESC Congress today. The results from the RECLOSE 2-ACS study were presented by Dr Rossella Marcucci from Italy.
› Verified 5 days ago